Komori
StemCell Institute (7096) · InitiativePlanned changes to the composition of the board and the proportion of women

Transparent Management and an Oversight Framework Led by Outside Directors

First written in FY2021. 3 of 6 entries say "Advanced", first in FY2023. Latest entry: FY2026.

6entries
6years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021 – FY2022AdvancedFY2023 – 2026-05-202021: 120212022: 120222023: 120232024: 020242025: 120252026: 22026
Same theme, other companies
Oversight structure involving outside directors and independent officersA theme 540 companies write about · 0 as a headwind · 549 as a tailwind

The whole theme swung hardest in 2023: 15 of 101 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 549 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Planned changes to the composition of the board and the proportion of womenAnnual report

    「If this proposal is approved, the company's officers will be as follows. The descriptions of officers' positions and other matters include the details of the positions and other matters to be resolved at the board meeting scheduled to be held immediately after the annual general meeting of shareholders.」

    As of the filing date, the company had 2 female officers and 6 outside officers. Following approval of the proposal at the general meeting of shareholders, it is stated that the company is expected to have 3 female officers, representing approximately 43%, 2 outside directors and 3 outside Audit & Supervisory Board Members.
  2. 2026-05-20AdvancedChanges in Officers

    「As a result, outside directors and outside audit & supervisory board members are expected to account for approximately 71% of all directors and audit & supervisory board members, while women are expected to account for approximately 43%. The Company recognizes governance as an important management issue, and will focus on high-quality discussions and swift decision-making by the Board of Directors, while working to strengthen its management control framework and promote diversity in its workforce.」

    The company presented planned ratios for outside officers and women, and specified initiatives to strengthen its management control framework and promote workforce diversity. The canonical thread remains unchanged.
  3. FY2025AdvancedAnnual report

    「At the annual general meeting of shareholders held on 23 June 2024, 2 female directors were appointed, bringing the proportion of female directors to approximately 28% (2/7) in the fiscal year ending March 2025. In addition, 6 of the 7 directors and Audit & Supervisory Board Members were outside officers, representing approximately 85%, strengthening management oversight.」

    The company specified a structure comprising 2 female officers, representing approximately 28%, and 6 outside officers, representing approximately 85%, with oversight by outside officers and diversity.
  4. FY2023AdvancedAnnual report

    「To establish a substantive governance structure at its listed subsidiary, the company has adopted as a basic policy an outside-director ratio of at least 1/3 on the board, and has appointed 3 outside directors and 3 outside Audit & Supervisory Board Members.」

    The number of outside directors increased from 2 in the previous fiscal year to 3, and an oversight structure including 3 outside Audit & Supervisory Board Members was presented. A tripartite audit meeting involving internal audits, Audit & Supervisory Board Member audits and accounting audits is also held in principle once every quarter.
  5. FY2022RestatedAnnual report

    「To establish a substantive governance structure at its listed subsidiary, the company has adopted as a basic policy an outside-director ratio of at least 1/3 on the board, and has appointed 2 outside directors and 2 outside Audit & Supervisory Board Members.」

    The company continues its oversight structure comprising 2 outside directors, an outside-director ratio of at least 1/3 on the board and 2 outside Audit & Supervisory Board Members, as well as board approval of related-party transactions.
  6. FY2021First statedAnnual report

    「The company believes that enhancing the soundness, transparency and objectivity of management is important for sustainably increasing corporate value. Accordingly, as part of its efforts to strengthen corporate governance, it will work to make the decision-making process more transparent, including by enhancing the number of outside directors.」

    As a listed company, it has established targets of 2 outside directors, an outside-director ratio of at least 1/3 on the board, and coordination among internal audits, Audit & Supervisory Board Member audits and accounting audits.
Moved together

"Recruitment and Development of Specialist Talent and Digitalization of Operations" moved the same way as this thread, in the same document, in 2 of its 6 moves.

222222★123456
  1. ★This thread
  2. 1Recruitment and Development of Specialist Talent and Digitalization of Operations2×
  3. 2Increase in the Annual Number of Stored Specimens and Improvement in the Equity Ratio2×
  4. 3Business expansion into cells derived from umbilical cord and other perinatal tissues2×
  5. 4Launch of Umbilical Cord Tissue Storage Service2×
  6. 5Support for Clinical Research in Regenerative Medicine and Cell Therapy Using Umbilical Cord Blood2×
  7. 6New Business Development Using Menstrual Blood-Derived Stem Cells and Culture-Derived Products2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for StemCell Institute yet. It last moved in the Changes in Officers of 2026-05-20: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.